Karolinska Institutet - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transcription

1 Karolinska Institutet - Pharmaceuticals & Healthcare - Deals and Alliances Profile

2 Karolinska Institutet - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 Karolinska Institutet - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Karolinska Institutet (KI) is a medical university that offers education services. The university provides education and research in the fields of medicine and health sciences. Its education courses include audiology, biomedicine, biomedical lab science, dental hygiene, medicine, nursing, occupational therapy and others. KI offers optometry, physiotherapy, psychology, public health science, speech and language pathology, and radiography. KI provides supplementary training on midwifery, and psychotherapy. It offers healthcare, education, research and development. The university s research areas include cancer and hematology, cell, molecular and structural biology, endocrinology and metabolism, epidemiology and public health sciences, and health care sciences. KI is headquartered in Stockholm, Sweden. Karolinska Institutet - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of 3

4 the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH68254D Number of Pages : 54 Report Format : PDF Publisher Information : 4

5 5

6 Table Of Contents for Karolinska Institutet - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: ] Table of Contents Table of Contents 3List of Tables 5List of Figures 5Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD Karolinska Institutet, Medical Devices Deals, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deal Details 13Partnerships 13NeuroVive Pharma Enters into Agreement with Karolinska Institutet 13Karolinska Institutet Partners with Johnson & Johnson Companies 14Canqura Oncology Enters into Agreement with Karolinska Institutet 15Lion Biotechnologies Enters into Clinical Trial Agreement with Karolinska University Hospital 16Sprint Bioscience Enters into Research Agreement with Karolinska Institutet 17Scancell Enters into Research Agreement with Karolinska Institutet 18Biovica Enters into Research Agreement with Karolinska Institutet 19Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 20Sorrento Therapeutics Enters into Partnership with Karolinska Institutet 21Thermo Fisher Scientific Enters into Agreement with Karolinska Institute 22Idogen Partners with Karolinska Institutet 23Moderna Therapeutics Enters into Discovery Agreement with Karolinska Institutet and Karolinska University Hospital 24Karolinska University Hospital Enters Into Research Agreement With GE Healthcare For Cell Therapy 25AVI BioPharma Enters Into Co-Development Agreement With Karolinska Institute 26Licensing Agreements 27Oblique Therapeutics Enters Licensing Agreement with National Institutes of Health and Karolinska Institutet 27Karolinska Institutet - Key Competitors 28Karolinska Institutet - Key Employees 29Karolinska Institutet - Locations And Subsidiaries 30Head Office 30Other Locations & Subsidiaries 30Recent Developments 31Government and Public Interest 31Jul 11, 2017: New tool demonstrates differences in human immune systems 31Jun 22, 2017: Presence of protein important clue to tumour regression in neuroblastoma 32Jun 09, 2017: Lithium medication protects against suicide 33Jun 07, 2017: Fewer relapses in schizophrenia with longacting injections 34Jun 06, 2017: New possible target for cancer treatment 35May 24, 2017: Making biological drugs with spider silk protein 36May 22, 2017: New findings on formation and malformation of blood vessels 37May 17, 2017: New way of preventing pneumococcal brain invasion 38May 16, 2017: Spread of tau protein measured in the brains of Alzheimer s patients 39May 15, 2017: Corticosteroid treatment increases survival of preterm infants within hours 40Mar 14, 2017: Major research project provides new clues to schizophrenia 41Feb 20, 2017: Hope for new treatment for Huntington s disease 43Feb 07, 2017: NattoPharma Named Partner For Horizon 2020 EU Research Grant 44Sep 23, 2016: Unique molecular atlas of pancreas produced 45Apr 12, 2016: Potential effects of fertility treatments on breast density and cancer risk 46Mar 08, 2016: New nanoparticle technology to decipher structure and function of membrane proteins 47Jan 27, 2016: Bactiguard: Study Shows That Coating Also Can Prevent Thrombosis 48Jan 26, 2016: 3D images reveal the body s guardian against urinary infection 49Product News 50Dec 12, 2016: The first-in-man clinical trial targeting Alzheimer's Tau protein 50Aug 12, 2016: A new method simplifies blood biomarker discovery and analysis 51Jul 11, 2017: New potential treatment for aggressive types of childhood cancer 52Jan 12, 2017: Inhibition of EZH2 might be new therapy of multiple myeloma 53Appendix 54Methodology 54About GlobalData 54Contact Us 54Disclaimer 54 6

7 List Of Tables in Karolinska Institutet - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: ] List of Tables Karolinska Institutet, Pharmaceuticals & Healthcare, Key Facts 2 Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD Karolinska Institutet, Deals By Therapy Area, 2011 to YTD Karolinska Institutet, Medical Devices Deals, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD NeuroVive Pharma Enters into Agreement with Karolinska Institutet 13 Karolinska Institutet Partners with Johnson & Johnson Companies 14 Canqura Oncology Enters into Agreement with Karolinska Institutet 15 Lion Biotechnologies Enters into Clinical Trial Agreement with Karolinska University Hospital 16 Sprint Bioscience Enters into Research Agreement with Karolinska Institutet 17 Scancell Enters into Research Agreement with Karolinska Institutet 18 Biovica Enters into Research Agreement with Karolinska Institutet 19 Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 20 Sorrento Therapeutics Enters into Partnership with Karolinska Institutet 21 Thermo Fisher Scientific Enters into Agreement with Karolinska Institute 22 Idogen Partners with Karolinska Institutet 23 Moderna Therapeutics Enters into Discovery Agreement with Karolinska Institutet and Karolinska University Hospital 24 Karolinska University Hospital Enters Into Research Agreement With GE Healthcare For Cell Therapy 25 AVI BioPharma Enters Into Co-Development Agreement With Karolinska Institute 26 Oblique Therapeutics Enters Licensing Agreement with National Institutes of Health and Karolinska Institutet 27 Karolinska Institutet, Key Competitors 28 Karolinska Institutet, Key Employees 29 Karolinska Institutet, Other Locations 30 Karolinska Institutet, Subsidiaries 30 7

8 List Of Figures, Charts and Diagrams in Karolinska Institutet - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: ] List of Figures Karolinska Institutet, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD Karolinska Institutet, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD Karolinska Institutet, Medical Devices Deals, 2011 to YTD

9 How to Buy... Karolinska Institutet - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: ] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9